慢性疾患管理市場の市場規模、シェア、成長分析、疾患タイプ別、管理タイプ別、エンドユース別、技術別、地域別 - 産業予測 2025年～2032年

慢性疾患管理の世界市場規模は2023年に61億米ドルと評価され、2024年の69億8,000万米ドルから2032年には206億3,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは14.5％で成長する見通しです。

世界の慢性疾患管理市場は、特に都市部におけるライフスタイルの変化に影響された慢性疾患の有病率の上昇によって大きな成長を遂げています。インターネットへのアクセシビリティが向上したことで、健康に対する意識が高まり、オンライン健康情報や遠隔医療サービスを利用する人が増えているため、ヘルスケア機関の患者基盤が拡大しています。さらに、都市部の大気汚染が呼吸器疾患の増加につながり、慢性疾患管理ソリューションの需要をさらに高めています。高齢者は長期的な健康問題を抱えやすいため、高齢化社会はさらに需要を高めています。さらに、ウェルネスプログラムを通じて従業員の健康を重視する企業が市場の成長を加速させており、多くの企業が従業員の健康をサポートするために慢性疾患管理イニシアチブに投資しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

慢性疾患管理市場規模：疾患タイプ別& CAGR（2025-2032）

• 市場概要
• 糖尿病
• 心血管疾患
• 慢性呼吸器疾患
• がん
• 慢性腎臓病

慢性疾患管理市場規模：管理タイプ別& CAGR（2025-2032）

• 市場概要
• ライフスタイル管理
• 薬物管理
• 遠隔医療サービス
• 患者教育
• 監視サービス

慢性疾患管理市場規模：エンドユース別& CAGR（2025-2032）

• 市場概要
• ヘルスケア提供者
• 患者
• 製薬会社
• 保険会社
• 調査機関

慢性疾患管理市場規模：技術別& CAGR（2025-2032）

• 市場概要
• ウェアラブルデバイス
• モバイルアプリケーション
• クラウドコンピューティング
• 電子健康記録
• 遠隔医療

慢性疾患管理市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024年）

主要企業プロファイル

• Optum, Inc.（USA）
• Medtronic（Ireland）
• Koninklijke Philips N.V.（Netherlands）
• Abbott Laboratories（USA）
• Siemens Healthineers（Germany）
• Cognizant（USA）
• Infosys Limited（India）
• EXL Service Holdings, Inc.（USA）
• Epic Systems Corporation（USA）
• WellSky（USA）
• ZeOmega（USA）
• Health Catalyst（USA）
• Pegasystems Inc.（USA）
• Cerner Corporation（USA）
• Humana Inc.（USA）
• Teladoc Health, Inc.（USA）
• ChartSpan（USA）
• Signallamp Health（USA）
• Engooden Health（USA）
• Optimize Health（USA）

結論と提言

Global Chronic Disease Management Market size was valued at USD 6.1 billion in 2023 and is poised to grow from USD 6.98 billion in 2024 to USD 20.63 billion by 2032, growing at a CAGR of 14.5% during the forecast period (2025-2032).

The global chronic disease management market is experiencing significant growth driven by the rising prevalence of chronic diseases, particularly in urban areas influenced by changing lifestyle patterns. Increased internet accessibility is enhancing health awareness and expanding Healthcare organizations' patient bases as more individuals utilize online health information and telemedicine services. Additionally, urban air pollution is contributing to a rise in respiratory diseases, further elevating the demand for chronic disease management solutions. The aging population adds another layer of demand, as older individuals are more prone to long-term health issues. Moreover, corporate emphasis on employee health through wellness programs accelerates market growth, with many companies investing in chronic disease management initiatives to support their workforce's well-being.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Chronic Disease Management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Chronic Disease Management Market Segments Analysis

Global Chronic Disease Management Market is segmented by Disease Type, Management Type, End Use, Technology and region. Based on Disease Type, the market is segmented into Diabetes, Cardiovascular Diseases, Chronic Respiratory Diseases, Cancer and Chronic Kidney Diseases. Based on Management Type, the market is segmented into Lifestyle Management, Medication Management, Telehealth Services, Patient Education and Monitoring Services. Based on End Use, the market is segmented into Healthcare Providers, Patients, Pharmaceutical Companies, Insurance Companies and Research Organizations. Based on Technology, the market is segmented into Wearable Devices, Mobile Applications, Cloud Computing, Electronic Health Records and Telemedicine. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Chronic Disease Management Market

The Global Chronic Disease Management market is experiencing substantial growth driven by rapid digitalization, which is significantly enhancing health awareness among individuals through real-time health monitoring technologies. Innovations such as smartwatches and fitness bands empower users to continuously track vital signs like blood pressure and heart rate, allowing them to monitor their health conditions effectively. As a result, people are increasingly proactive about their well-being, leading to a rise in patient consultations for fitness and health management. This trend underscores the importance of leveraging technology in chronic disease management, fostering a more informed and health-conscious population.

Restraints in the Global Chronic Disease Management Market

While technological advancements in the healthcare sector are significantly benefiting developed economies, several factors could hinder the growth of the global chronic disease management market. In low-income countries, budget limitations pose challenges to effective treatment for chronic diseases. These financial restrictions prevent the adoption of new technologies within their healthcare systems, ultimately affecting medical outcomes. The disparity in resources and lack of infrastructure in these regions can create a substantial barrier to progress, leading to a slower evolution in chronic disease management practices. Therefore, addressing these constraints is essential for achieving equitable healthcare improvements globally.

Market Trends of the Global Chronic Disease Management Market

The Global Chronic Disease Management market is witnessing a significant shift driven by the rapid development and integration of telemedicine and remote monitoring technologies. This trend has been accelerated by the COVID-19 pandemic, highlighting the necessity of efficient healthcare delivery systems. Telemedicine facilitates convenient consultations for patients, particularly in underserved and rural regions, improving access to essential medical services. Furthermore, remote monitoring allows healthcare providers to track symptoms and health indicators in real-time, promoting early interventions that enhance patient outcomes. As a result, the market is poised for growth, characterized by an increasing demand for innovative solutions that enable effective management of chronic diseases.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Chronic Disease Management Market Size by Disease Type & CAGR (2025-2032)

• Market Overview
• Diabetes
• Cardiovascular Diseases
• Chronic Respiratory Diseases
• Cancer
• Chronic Kidney Diseases

Global Chronic Disease Management Market Size by Management Type & CAGR (2025-2032)

• Market Overview
• Lifestyle Management
• Medication Management
• Telehealth Services
• Patient Education
• Monitoring Services

Global Chronic Disease Management Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Healthcare Providers
• Patients
• Pharmaceutical Companies
• Insurance Companies
• Research Organizations

Global Chronic Disease Management Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Wearable Devices
• Mobile Applications
• Cloud Computing
• Electronic Health Records
• Telemedicine

Global Chronic Disease Management Market Size & CAGR (2025-2032)

• North America (Disease Type, Management Type, End Use, Technology)
  • US
  • Canada
• Europe (Disease Type, Management Type, End Use, Technology)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Disease Type, Management Type, End Use, Technology)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Disease Type, Management Type, End Use, Technology)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Disease Type, Management Type, End Use, Technology)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Optum, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cognizant (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Infosys Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EXL Service Holdings, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Epic Systems Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WellSky (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZeOmega (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Health Catalyst (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pegasystems Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerner Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Humana Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teladoc Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ChartSpan (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Signallamp Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Engooden Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Optimize Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations